TY  - JOUR
AU  - Librero Jiménez, Marta
AU  - Heredia Carrasco, Clara
AU  - Fernández Cano, María Del Carmen
PY  - 2022
DO  - 10.17235/reed.2020.7585/2020
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21700
T2  - Revista espanola de enfermedades digestivas
AB  - Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.
LA  - en
KW  - Chemical and Drug Induced Liver Injury
KW  - Humans
KW  - Idiopathic Pulmonary Fibrosis
KW  - Indoles
TI  - Severe hepatotoxicity secondary to nintedanib.
TY  - research article
VL  - 114
ER  -